Mineralys Therapeutics Inc (MLYS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MLYS Annual Balance Sheets →
Examining balance sheet movements between Mineralys Therapeutics Inc and Jun 30 2025 reveals how Jun 30 2026 adjusts its asset composition and liability profile.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent138.27
Marketable Securities535.44
Short-term Investments661.40
Cash & Short-term Investments1,334.00
Derivatives, Collateral, Regulatory, Deferred0.20
Other Current Assets0.00
Prepaid Expense And Other Assets Current4.39
Total Current Assets665.80
Equipment/Property/Plant Net0.03
Deferred, Prepaid and Other Assets, Noncurrent0.40
Other Assets, Noncurrent1.62
Debt Securities Current533.28
Total Assets667.85
Liabilities
Accounts Payable, Current AC1.07
Accrued Liabilities, Current AC18.25
Total Current Liabilities19.32
Long-term debt0.10
Long-term Debt Convertible2.00
Total Long-term Debt2.10
Other liabilities, Noncurrent95.52
Total Liabilities116.94
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,288.49
Retained Earnings / Accumulated Deficit-737.58
Other Equity0.00
Common Stockholder's Equity550.92
Total Stockholder's Equity550.92
Liabilities & Stockholder's Equity667.85
4 historic quarters locked

Sign in to unlock the full Mineralys Therapeutics Inc balance sheet history.

About Mineralys Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001933414-26-000114

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.